Next up the NATA plenary session. @TobyRichardsUCL on 'cheap and quick wins in PBM' #bbts2017
@TobyRichardsUCL Either oral or IV iron are useful in pre op setting #bbts2017
@TobyRichardsUCL Clinical trials are important. PREVENTT has now recruited >400 patients. Do the #haemSpRs know what PREVENTT is studying? #bbts2017
@TobyRichardsUCL BRIDGE study showed bridging prob only beneficial in those with mechanical heart valve #bbts2017 nejm.org/doi/full/10.10…
@TobyRichardsUCL ATACUS study in cardiac surgical patients (NEJM 2016) showed no difference in outcomes for stopping antiplt or not... 1/2
@TobyRichardsUCL 2/2... with less bleeding in those who stopped #bbts2017
@TobyRichardsUCL Safety of cell salvage in patients with malignancy? REview article here ncbi.nlm.nih.gov/pubmed/22996966 #bbts2017
@TobyRichardsUCL Prof Richards would rather have his own blood back in the setting of malig (through a filter) than allogeneic transfusion #bbts2017
@TobyRichardsUCL National Comparative Audit of surgical PBM showed long times from listing to surgery - adequate time to intervene. Good use of ...1/2
@TobyRichardsUCL 2/2... single units but less use of TXA and ICS #bbts2017 hospital.blood.co.uk/media/28123/20…
@TobyRichardsUCL Biggest yields are from stopping antiplatelets pre op, using ICS and managing anaemia, reducing LOS by 31, 18 and 7% respectively #bbts2017
@TobyRichardsUCL Prof Richards says the onus for pre op management is on the surgeons. Couldn't agree more. But how to engage them?! #bbts2017
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.